ID: ALA232642

Max Phase: Preclinical

Molecular Formula: C7H7NO2

Molecular Weight: 137.14

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): N-Hydroxyformanilide
Synonyms from Alternative Forms(1):

    Canonical SMILES:  O=CN(O)c1ccccc1

    Standard InChI:  InChI=1S/C7H7NO2/c9-6-8(10)7-4-2-1-3-5-7/h1-6,10H

    Standard InChI Key:  FWUDLKMCWUETIP-UHFFFAOYSA-N

    Associated Targets(non-human)

    Mandelate racemase 27 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 137.14Molecular Weight (Monoisotopic): 137.0477AlogP: 1.04#Rotatable Bonds: 2
    Polar Surface Area: 40.54Molecular Species: NEUTRALHBA: 2HBD: 1
    #RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 9.12CX Basic pKa: CX LogP: 0.80CX LogD: 0.79
    Aromatic Rings: 1Heavy Atoms: 10QED Weighted: 0.38Np Likeness Score: -0.31

    References

    1. Bourque JR, Burley RK, Bearne SL..  (2007)  Intermediate analogue inhibitors of mandelate racemase: N-Hydroxyformanilide and cupferron.,  17  (1): [PMID:17055725] [10.1016/j.bmcl.2006.09.079]

    Source